최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기精神身體醫學 = Korean journal of psychosomatic medicine, v.27 no.2, 2019년, pp.155 - 163
정재윤 (인제대학교 의과대학 일산백병원 정신건강의학교실) , 이강준 (인제대학교 의과대학 일산백병원 정신건강의학교실) , 김현 (인제대학교 의과대학 일산백병원 정신건강의학교실)
Objectives : The aim of this study was to compare severity, neurocognitive functions, and behavioral and psychological symptoms of dementia (BPSD) according to the degree of temporal lobe atrophy (MTA) in Korean patients with dementia due to Alzheimer's disease and mild cognitive impairment due to A...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
치매란? | 치매는 대뇌 피질의 신경퇴행성 변화가 나타나 기억력, 판단력, 실행기능 등의 인지기능 장애 및 망상, 초조, 불안, 배회 등의 행동심리증상(Behavioral and Psychological Symptoms of Dementia, BPSD)을 보이는 장애이다. 많은 환자들은 인지기능장애 뿐만 아니라 BPSD를 보이는데 알츠하이머병 환자에서 BPSD의 유병률은 75~90% 정도로 높게 보고되고 있으며,1) 무감각, 우울, 불안 및 이상 운동 등이 흔하게 나타나는 증상들이다. | |
시각 기반 정성 평가의 장점은? | 내측두엽 위축을 평가하는 방법은 다양하지만, 그 중에서도 임상의가 직접 뇌 영상 검사 결과를 보면서 수행하는 시각 기반 정성 평가는 적절한 훈련 뒤에 간편하게 적용할 수 있다는 장점을 가진다. 그러나 이를 이용한 평가의 유용성 및 진단적 의의에 대해서는 아직 연구가 많이 부족한 상황이다. | |
알츠하이머병 환자에 나타나는 행동심리증상은 무엇인가? | 치매는 대뇌 피질의 신경퇴행성 변화가 나타나 기억력, 판단력, 실행기능 등의 인지기능 장애 및 망상, 초조, 불안, 배회 등의 행동심리증상(Behavioral and Psychological Symptoms of Dementia, BPSD)을 보이는 장애이다. 많은 환자들은 인지기능장애 뿐만 아니라 BPSD를 보이는데 알츠하이머병 환자에서 BPSD의 유병률은 75~90% 정도로 높게 보고되고 있으며,1) 무감각, 우울, 불안 및 이상 운동 등이 흔하게 나타나는 증상들이다.2) |
Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. Jama 2002;288:1475-1483.
Piccininni M, Di Carlo A, Baldereschi M, Zaccara G, Inzitari D. Behavioral and psychological symptoms in Alzheimer's disease: Frequency and relationship with duration and severity of the disease. Dement Geriatr Cogn Disord 2005;19:276-281.
Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Wolters Kluwer;2016. p.704-740.
Yilmaz R, Pilotto A, Roeben B, Preische O, Suenkel U, Heinzel S, Metzger FG, Laske C, Maetzler W, Berg D. Structural Ultrasound of the Medial Temporal Lobe in Alzheimer's Disease. Ultraschall Med 2017;38:294-300.
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
Overdorp EJ, Kessels RP, Claassen JA, Oosterman JM. Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients. Front Aging Neurosci 2014;6:98.
Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 1996;44:44-49.
Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro MB. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998;43:60-68.
Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004;27:279-306.
Burns A, Jacoby R, Levy R. Psychiatric phenomena in alzheimer's disease. Iv: Disorders of behaviour. Br J Psychiatry 1990;157:86-94.
Garcia-Alberca JM, Florido M, Caceres M, Sanchez-Toro A, Lara JP, Garcia-Casares N. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease. Psychogeriatrics 2019;19:46-54.
Staekenborg SS, Gillissen F, Romkes R, Pijnenburg YA, Barkhof F, Scheltens P, van der Flier WM. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease. Int J Geriatr Psychiatry 2008;23:387-392.
Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment. PLoS One 2015;10:e0137121.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the Nincds-Adrda Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
Claus JJ, Staekenborg SS, Holl DC, Roorda JJ, Schuur J, Koster P, Tielkes CEM, Scheltens P. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population. Eur Radiol 2017;27:3147-3155.
Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; Add-NeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in alzheimer's disease and mild cognitive impairment. J Intern Med 2015;278:277-290.
Velickaite V, Ferreira D, Cavallin L, Lind L, Ahlstrom H, Kilander L, Westman E, Larsson EM. Medial temporal lobe atrophy ratings in a large 75-year-old population-based cohort: gender-corrected and education-corrected normative data. Eur Radiol 2018;28:1739-1747.
Choi L, Joo SH, Lee CU, Paik IH. Association between Global Cortical Atrophy, Medial Temporal Atrophy, White Matter Hyperintensities and Cognitive Functions in Korean Alzheimer's Disease Patients. Korean J Biol Psychiatry 2015;22:140-148.
Morris JC. The Clinical Dementia Rating (Cdr): current version and scoring rules. Neurology 1993;43:2412-2414.
Reisberg B, Ferris SH, de Leon MJ, Crook T. Global Deterioration Scale (Gds). Psychopharmacol Bull 1988;24:661-663.
Fillenbaum GG, Heyman A, Wilkinson WE, Haynes CS. Comparison of two screening tests in Alzheimer's disease. The correlation and reliability of the Mini-Mental State Examination and the modified Blessed test. Arch Neurol 1987;44:924-927.
Lee DY, Yoon JC, Lee KU, Jhoo JH, Kim KW, Lee JH, Woo JI. Reliability and Validity of the Korean Version of Short Blessed Test(Sbt-K) as a Dementia Screening Instrument. J Korean Neuropsychiatr Assoc 1999;38:1365-1375.
Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, Lee KH, Kim SY, Han SH, Woo JI. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (Cerad-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:47-53.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
Persson K, Barca ML, Cavallin L, Brækhus A, Knapskog AB, Selbaek G, Engedal K. Comparison of automated volumetry of the hippocampus using $Neuroquant^{(R)}$ and visual assessment of the medial temporal lobe in Alzheimer's disease. Acta Radiol 2018;59:997-1001.
Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR Jr, Lovblad KO, Frisoni GB, Scheltens P; Geneva Task Force for the Roadmap of Alzheimer's Biomarkers. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiol Aging 2017;52:167-182.
Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 2015;86:1225-1233.
Dhikav V, Sethi M, Anand KS. Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression. Br J Radiol 2014;87:20140150.
Persson K, Barca ML, Eldholm RS, Cavallin L, Saltyte Benth J, Selbæk G, Brækhus A, Saltvedt I, Engedal K. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Dement Geriatr Cogn Disord 2017;44:12-24.
Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012;135:1860-1870.
Matthews BR. Memory dysfunction. Continuum (Minneap Minn) 2015;21:613-626.
Laakso MP, Soininen H, Partanen K, Helkala EL, Hartikainen P, Vainio P, Hallikainen M, Hanninen T, Riekkinen PJ Sr. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect 1995;9:73-86.
Stout JC, Bondi MW, Jernigan TL, Archibald SL, Delis DC, Salmon DP. Regional cerebral volume loss associated with verbal learning and memory in dementia of the Alzheimer type. Neuropsychology 1999;13:188-197.
Beck IR, Gagneux-Zurbriggen A, Berres M, Taylor KI, Monsch AU. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (Cerad-Nab) versus California Verbal Learning Test (CVLT). Arch Clin Neuropsychol 2012 27:510-519.
Dos Santos V, Thomann PA, Wustenberg T, Seidl U, Essig M, Schroder J. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011;23:411-420.
Lorentz WJ, Scanlan JM, Borson S. Brief screening tests for dementia. Can J Psychiatry 2002;47:723-733.
Kandiah N, Chander R, Zhang A, Yee CC. Cerebral white matter disease is independently associated with BPSD in Alzheimer's disease. J Neurol Sci 2014;337:162-166.
Palmqvist S, Sarwari A, Wattmo C, Bronge L, Zhang Y, Wahlund LO, Nagga K. Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2011;32:417-423.
Ogama N, Sakurai T, Saji N, Nakai T, Niida S, Toba K, Umegaki H, Kuzuya M. Frontal White Matter Hyperintensity Is Associated with Verbal Aggressiveness in Elderly Women with Alzheimer Disease and Amnestic Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra 2018;8:138-150.
Kang DW, Lim HK. Current Knowledge and Clinical Application of Brain Imaging in Alzheimer's Disease. J Korean Neuropsychiatr Assoc 2018;57:12-22.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.